Patent ID: 11945824
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The compound of claim 1, represented by one of Formulae (XIa)˜(XId), or a pharmaceutically acceptable salt thereof:, , wherein R11 is independently optionally substituted —C1-C6 alkyl, optionally substituted C1-C6 alkoxyl, optionally substituted —C3-C6 cycloalkyl, halo, —CN, or —NRaRb; Ra and Rb are independently selected from hydrogen, optionally substituted —C1-C6 alkyl, optionally substituted —C3-C6 cycloalkyl, alternatively, Ra and Rb are taken together with nitrogen atom to which they attached to form a heterocyclic ring; each p is independently 0, 1, 2 or 3; p′ is 0, or 1; each m is 0, 1, 2, 3, 4 or 5, m′ is independently 0, 1, 2 or 3; and Y, G, R3, R4, are as defined in claim 1.